Altered natural killer (NK) cell frequency and phenotype in latent autoimmune diabetes in adults (LADA) prior to insulin deficiency (Q84086506)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20408863%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

title

Altered natural killer (NK) cell frequency and phenotype in latent autoimmune diabetes in adults (LADA) prior to insulin deficiency (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20408863%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

author name string

C Akesson

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20408863%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

K Uvebrant

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20408863%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

C Oderup

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20408863%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

K Lynch

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20408863%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

R A Harris

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20408863%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

A Lernmark

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20408863%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

C-D Agardh

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20408863%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

C M Cilio

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20408863%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

publication date

9 April 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20408863%20AND%20SRC:MED&resulttype=core&format=json

Clinical and Experimental Immunology

31 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20408863%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

volume

161

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20408863%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

page(s)

48-56

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20408863%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20408863%20AND%20SRC:MED&resulttype=core&format=json

CD4+CD25+ T regulatory cells inhibit cytotoxic activity of T CD8+ and NK lymphocytes in the direct cell-to-cell interaction

31 January 2020

cites work

1 reference

12 December 2020

Autoimmune diabetes mellitus--much progress, but many challenges

1 reference

12 December 2020

Alterations in lymphocyte subpopulations in type 1 (insulin-dependent) diabetes mellitus: exploration of possible mechanisms and relationships to autoimmune phenomena

1 reference

12 December 2020

Islet cell antibodies identify latent type I diabetes in patients aged 35-75 years at diagnosis.

1 reference

12 December 2020

Natural killer cells in insulin dependent diabetes mellitus

1 reference

12 December 2020

Natural killer cell and islet killer cell activities in type 1 (insulin-dependent) diabetes

1 reference

12 December 2020

Immunoregulatory dysfunctions in type I diabetes: natural and antibody-dependent cellular cytotoxic activities

1 reference

12 December 2020

Evidence that the reduced number of natural killer cells in type 1 (insulin-dependent) diabetes may be genetically determined

1 reference

12 December 2020

Immune responses to insulin and lymphocyte subclasses at diagnosis of insulin-dependent diabetes and one year later

1 reference

12 December 2020

Quantitative assay using recombinant human islet glutamic acid decarboxylase (GAD65) shows that 64K autoantibody positivity at onset predicts diabetes type

1 reference

12 December 2020

Antibodies to glutamic acid decarboxylase reveal latent autoimmune diabetes mellitus in adults with a non-insulin-dependent onset of disease

1 reference

12 December 2020

Cytotoxic activity in children with insulin-dependent diabetes mellitus

1 reference

12 December 2020

Latent autoimmune diabetes mellitus in adults (LADA): the role of antibodies to glutamic acid decarboxylase in diagnosis and prediction of insulin dependency

1 reference

12 December 2020

NKB1: a natural killer cell receptor involved in the recognition of polymorphic HLA-B molecules

1 reference

12 December 2020

A novel radioligand binding assay to determine diagnostic accuracy of isoform-specific glutamic acid decarboxylase antibodies in childhood IDDM

1 reference

12 December 2020

The Bw4 public epitope of HLA-B molecules confers reactivity with natural killer cell clones that express NKB1, a putative HLA receptor

1 reference

12 December 2020

Validation of allele-specific polymerase chain reaction for DNA typing of HLA-B27

1 reference

12 December 2020

Triple-label hybridization assay for type-1 diabetes-related HLA alleles

1 reference

12 December 2020

GAD antibodies in NIDDM. Ten-year follow-up from the diagnosis

1 reference

12 December 2020

Rapid HLA-DQB1 genotyping for four alleles in the assessment of risk for IDDM in the Finnish population. The Childhood Diabetes in Finland (DiMe) Study Group

1 reference

12 December 2020

UKPDS 25: autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes

1 reference

12 December 2020

The immunoregulatory effects of NK cells: the role of TGF-beta and implications for autoimmunity

1 reference

12 December 2020

Regulation of adaptive immunity by natural killer cells

1 reference

12 December 2020

A simple and rapid microSepharose assay for GAD65 and ICA512 autoantibodies in diabetes. Diabetes Incidence Study in Sweden (DISS).

1 reference

12 December 2020

Activating and inhibitory NK cell receptors

1 reference

12 December 2020

Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies.

1 reference

12 December 2020

Regulation of immune responses through inhibitory receptors

1 reference

12 December 2020

MHC class I molecules and KIRs in human history, health and survival

1 reference

12 December 2020

Accelerated chemically induced tumor development mediated by CD4+CD25+ regulatory T cells in wild-type hosts

1 reference

12 December 2020

Activation of human NK cells by plasmacytoid dendritic cells and its modulation by CD4+ T helper cells and CD4+ CD25hi T regulatory cells.

1 reference

12 December 2020

CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor-beta-dependent manner

1 reference

12 December 2020

Insulin and glucagon secretion in patients with slowly progressing autoimmune diabetes (LADA).

1 reference

12 December 2020

CD4+CD25high regulatory cells in human peripheral blood

1 reference

12 December 2020

The role of NK cells in autoimmune disease

1 reference

12 December 2020

Impairment of NK cell function by NKG2D modulation in NOD mice

1 reference

12 December 2020

Immune functions encoded by the natural killer gene complex

1 reference

12 December 2020

What does it take to make a natural killer?

1 reference

12 December 2020

The enigma of the natural killer cell

1 reference

12 December 2020

NK cells: elusive players in autoimmunity

1 reference

12 December 2020

CD4+CD25+ T regulatory cells suppress NK cell-mediated immunotherapy of cancer

1 reference

12 December 2020

Suppression of natural killer cell-mediated bone marrow cell rejection by CD4+CD25+ regulatory T cells

1 reference

12 December 2020

The regulatory effect of natural killer cells: do "NK-reg cells" exist?

1 reference

12 December 2020

Altered natural killer cells in type 1 diabetic patients.

1 reference

12 December 2020

Natural killer cells prevent CD28-mediated Foxp3 transcription in CD4+CD25- T lymphocytes

1 reference

12 December 2020

T regulatory cells control numbers of NK cells and CD8alpha+ immature dendritic cells in the lymph node paracortex.

1 reference

12 December 2020

NK cells lyse T regulatory cells that expand in response to an intracellular pathogen

1 reference

12 December 2020

Regulatory T cells control dendritic cell/NK cell cross-talk in lymph nodes at the steady state by inhibiting CD4+ self-reactive T cells

1 reference

12 December 2020

The NKG2D receptor: sensing stressed cells

1 reference

12 December 2020

Functions of natural killer cells

1 reference

12 December 2020

NK cells and Treg cells: a fascinating dance cheek to cheek

1 reference

12 December 2020

Clinical and pathogenic significance of pancreatic-islet-cell antibodies in diabetics treated with oral hypoglycaemic agents

1 reference

12 December 2020

10.1111/J.1365-2249.2010.04114.X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20408863%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

0 references

1 reference